Adults with late stage 3 chronic kidney disease are at high risk for prevalent silent brain infarction: A population-based study

Stroke

Volumn 42, Issue 8, 2011, Pages 2120-2125

  Chou, Chia Chi ^a   Lien, Li Ming ^b   Chen, Wei Hung ^b   Wu, Mai Szu ^a,c   Lin, Shiue Ming ^b,f   Chiu, Hou Chang ^b,d   Chiou, Hung Yi ^e   Bai, Chyi Huey ^b,e,f  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

chronic kidney disease; magnetic resonance imaging; silent brain infarction

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; BRAIN INFARCTION; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; RANDOM SAMPLE; RANDOMIZED CONTROLLED TRIAL; SEX RATIO; SILENT BRAIN INFARCTION; SINGLE BLIND PROCEDURE; URIC ACID BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RISK; STROKE; TAIWAN;

EID: 79961210202     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.597930     Document Type: Article

References (45)

1. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: A systematic review. Lancet Neurol. 2007;6:611-619. (Pubitemid 46921055)
2. Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke. 1997;28: 1932-1939. (Pubitemid 27458998)
3. Bernick C, Kuller L, Dulberg C, Longstreth WT Jr, Manolio T, Beauchamp N, et al. Silent MRI infarcts and the risk of future stroke: The cardiovascular health study. Neurology. 2001;57:1222-1229. (Pubitemid 32947380)
4. Longstreth WT Jr, Dulberg C, Manolio TA, Lewis MR, Beauchamp NJ Jr, O'Leary D, et al. Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: The Cardiovascular Health Study. Stroke. 2002;33:2376-2382.
5. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: Effects on the cardiovascular system. Circulation. 2007;116:85-97. (Pubitemid 47016250)
6. Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol. 2002;13:745-753. (Pubitemid 34183941)
7. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305.
8. Naganuma T, Uchida J, Tsuchida K, Takemoto Y, Tatsumi S, Sugimura K, et al. Silent cerebral infarction predicts vascular events in hemodialysis patients. Kidney Int. 2005;67:2434-2439. (Pubitemid 41623407)
9. Nakatani T, Naganuma T, Uchida J, Masuda C, Wada S, Sugimura T, et al. Silent cerebral infarction in hemodialysis patients. Am J Nephrol. 2003;23:86-90. (Pubitemid 36164601)
10. Kobayashi S, Ikeda T, Moriya H, Ohtake T, Kumagai H. Asymptomatic cerebral lacunae in patients with chronic kidney disease. Am J Kidney Dis. 2004;44:35-41. (Pubitemid 38880924)
11. Wada M, Nagasawa H, Iseki C, Takahashi Y, Sato H, Arawaka S, et al. Cerebral small vessel disease and chronic kidney disease (CKD): Results of a cross-sectional study in community-based Japanese elderly. J Neurol Sci. 2008;272:36-42.
12. Ikram MA, Vernooij MW, Hofman A, Niessen WJ, van der Lugt A, Breteler MM. Kidney function is related to cerebral small vessel disease. Stroke. 2008;39:55-61.
13. Kobayashi M, Hirawa N, Yatsu K, Kobayashi Y, Yamamoto Y, Saka S, et al. Relationship between silent brain infarction and chronic kidney disease. Nephrol Dial Transplant. 2009;24:201-207.
14. Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, et al. Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol. 2002;13:806-816. (Pubitemid 34183950)
15. Peralta CA, Katz R, Madero M, Sarnak M, Kramer H, Criqui MH, et al. The differential association of kidney dysfunction with small and large arterial elasticity: The multiethnic study of atherosclerosis. Am J Epidemiol. 2009;169:740-748.
16. Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol. 2009;78:539-552.
17. Hsieh YC, Hung CT, Lien LM, Bai CH, Chen WH, Yeh CY, et al. A significant decrease in blood pressure through a family-based nutrition health education programme among community residents in Taiwan. Public Health Nutr. 2009;12:570-577.
18. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247-254. (Pubitemid 46768608)
19. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-S266.
20. Vermeer SE, Den Heijer T, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM. Incidence and risk factors of silent brain infarcts in the population-based rotterdam scan study. Stroke. 2003;34:392-396. (Pubitemid 36206336)
21. Yovchevski P, Goshev E, Kostov K. Chronic kidney disease, hypertension and silent brain infarction. Nephrol Dial Transplant. 2008;23:4083.
22. Bokura H, Yamaguchi S, Iijima K, Nagai A, Oguro H. Metabolic syndrome is associated with silent ischemic brain lesions. Stroke. 2008;39:1607-1609.
23. Asumi M, Yamaguchi T, Saito K, Kodama S, Miyazawa H, Matsui H, et al. Are serum cholesterol levels associated with silent brain infarcts? The Seiryo Clinic Study. Atherosclerosis. 2010;210:674-677.
24. Kwon HM, Kim BJ, Lee SH, Choi SH, Oh BH, Yoon BW. Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. Stroke. 2006;37:466-470.
25. Nomura K, Hamamoto Y, Takahara S, Kikuchi O, Honjo S, Ikeda H, et al. Relationship between carotid intima-media thickness and silent cerebral infarction in Japanese subjects with type 2 diabetes. Diabetes Care. 2010;33:168-170.
26. Yoshida M, Higashi K, Kobayashi E, Saeki N, Wakui K, Kusaka T, et al. Correlation between images of silent brain infarction, carotid atherosclerosis and white matter hyperintensity, and plasma levels of acrolein, IL-6 and CRP. Atherosclerosis. 2010;211:475-479.
27. Khatri M, Wright CB, Nickolas TL, Yoshita M, Paik MC, Kranwinkel G, et al. Chronic kidney disease is associated with white matter hyperintensity volume: The Northern Manhattan Study (NOMAS). Stroke. 2007; 38:3121-3126. (Pubitemid 350175724)
28. Martinez-Vea A, Salvadó E, Bardají A, Gutierrez C, Ramos A, García C, et al. Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD. Am J Kidney Dis. 2006;47:241-250. (Pubitemid 43121327)
29. Bugnicourt JM, Chillon JM, Godefroy O, Massy ZA. Relationship between silent brain infarction and chronic kidney disease. Nephrol Dial Transplant. 2009;24:2005; author reply 2005-2007.
30. Lastilla M. Lacunar infarct. Clin Exp Hypertens. 2006;28:205-215. (Pubitemid 44178491)
31. Matsusue E, Sugihara S, Fujii S, Ohama E, Kinoshita T, Ogawa T. White matter changes in elderly people: MR-pathologic correlations. Magn Reson Med Sci. 2006;5:99-104.
32. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43:1683-1689. (Pubitemid 23307935)
33. Knottnerus IL, Ten Cate H, Lodder J, Kessels F, van Oostenbrugge RJ. Endothelial dysfunction in lacunar stroke: A systematic review. Cerebrovasc Dis. 2009;27:519-526.
34. Harrison LC, Raunio M, Holli KK, Luukkaala T, Savio S, Elovaara I, et al. MRI texture analysis in multiple sclerosis: Toward a clinical analysis protocol. Acad Radiol. 2010;17:696-707.
35. Mulder C, Scheltens P, Barkhof F, Gundy C, Verstraeten RA, de Leeuw FE. Low vitamin B6 levels are associated with white matter lesions in Alzheimer's disease. J Am Geriatr Soc. 2005;53:1073-1074. (Pubitemid 41647611)
36. Lemos MM, Jancikic AD, Sanches FM, Christofalo DM, Ajzen SA, Carvalho AB, et al. Intima-media thickness is associated with inflammation and traditional cardiovascular risk factors in non-dialysis-dependent patients with chronic kidney disease. Nephron Clin Pract. 2010;115:c189-c194.
37. Matsuda N, Takei T, Fujiu A, Ogawa T, Nitta K. Arterial stiffness in patients with non-diabetic chronic kidney disease (CKD). J Atheroscler Thromb. 2009;16:57-62.
38. Coll B, Betriu A, Martínez-Alonso M, Borràs M, Craver L, Amoedo ML, et al. Cardiovascular risk factors underestimate atherosclerotic burden in chronic kidney disease: Usefulness of non-invasive tests in cardiovascular assessment. Nephrol Dial Transplant. 2010;25:3017-3025.
39. Upadhyay A, Hwang SJ, Mitchell GF, Vasan RS, Vita JA, Stantchev PI, et al. Arterial stiffness in mild-to-moderate CKD. J Am Soc Nephrol. 2009;20:2044-2053.
40. Sengstock D, Sands RL, Gillespie BW, Zhang X, Kiser M, Eisele G, et al. Dominance of traditional cardiovascular risk factors over renal function in predicting arterial stiffness in subjects with chronic kidney disease. Nephrol Dial Transplant. 2010;25:853-861.
41. Ford ML, Tomlinson LA, Chapman TP, Rajkumar C, Holt SG. Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4. Hypertension. 2010;55:1110-1115.
42. Uzu T, Kida Y, Shirahashi N, Harada T, Yamauchi A, Nomura M, et al. Cerebral microvascular disease predicts renal failure in type 2 diabetes. J Am Soc Nephrol. 2010;21:520-526.
43. Price TR, Manolio TA, Kronmal RA, Kittner SJ, Yue NC, Robbins J, et al. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The cardiovascular health study. CHS Collaborative Research Group. Stroke. 1997;28:1158-1164. (Pubitemid 27248888)
44. Schmidt R, Ropele S, Enzinger C, Petrovic K, Smith S, Schmidt H, et al. White matter lesion progression, brain atrophy, and cognitive decline: The Austrian stroke prevention study. Ann Neurol. 2005;58:610-616. (Pubitemid 41377225)
45. Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, Tsai SP, et al. All-cause mortality attributable to chronic kidney disease: A prospective cohort study based on 462 293 adults in Taiwan. Lancet. 2008;371: 2173-2182. (Pubitemid 351890412)